A detailed history of Traub Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Traub Capital Management LLC holds 1,169 shares of ABBV stock, worth $273,546. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,169
Previous 1,169 -0.0%
Holding current value
$273,546
Previous $217 Million 24.74%
% of portfolio
0.27%
Previous 0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$170.16 - $206.27 $198,917 - $241,129
1,169 New
1,169 $217 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Traub Capital Management LLC Portfolio

Follow Traub Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traub Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traub Capital Management LLC with notifications on news.